Results 271 to 280 of about 207,511 (311)
Some of the next articles are maybe not open access.
Lung transplantation for interstitial lung disease
Clinics in Chest Medicine, 2004Lung transplantation remains the only therapeutic option shown to improve survival for many end-stage interstitial lung diseases. Although idiopathic pulmonary fibrosis is the most common indication, transplantation has been performed for many other diseases.
Brandon S, Lu, Sangeeta M, Bhorade
openaire +2 more sources
Interstitial Lung Disease and Lung Transplantation
Seminars in Respiratory and Critical Care Medicine, 2010Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias and carries the worst prognosis. Currently the best treatment option is lung transplantation. Historically patients with IPF had poor outcomes following referral for lung transplant due to high waiting-list mortality. The introduction of the lung allocation
Sarah, O'Beirne +2 more
openaire +2 more sources
Lung transplantation in interstitial lung disease
Current Opinion in Pulmonary Medicine, 2001Interstitial lung disease is a heterogeneous group of illnesses, some of which may progress to a fibrosing stage and cause respiratory failure. For selected candidates, lung transplantation is the ultimate therapeutic option. We review data on lung transplantation for various interstitial lung diseases.
R, Sulica, A, Teirstein, M L, Padilla
openaire +2 more sources
Lung transplantation and interstitial lung disease
Current Opinion in Pulmonary Medicine, 2005Interstitial lung disease includes a heterogeneous group of disorders that leads to respiratory insufficiency and death in a significant number of patients. Lung transplantation is a therapeutic option in select candidates.The indications, transplant procedure options, and outcomes continue to evolve.
Raed, Alalawi +3 more
openaire +2 more sources
Deutsche medizinische Wochenschrift (1946), 2011
This concise article summarizes recent advances in the field of interstitial lung disease (ILD) with particular focus on clinically relevant findings. As a novel treatment option for idiopathic pulmonary fibrosis (IPF), pirfenidone has been granted marketing authorization in the European Union for the treatment of mild to moderate IPF. In contrast, the
D, von der Beck, A, Günther, P, Markart
openaire +2 more sources
This concise article summarizes recent advances in the field of interstitial lung disease (ILD) with particular focus on clinically relevant findings. As a novel treatment option for idiopathic pulmonary fibrosis (IPF), pirfenidone has been granted marketing authorization in the European Union for the treatment of mild to moderate IPF. In contrast, the
D, von der Beck, A, Günther, P, Markart
openaire +2 more sources
Lung transplantation for interstitial lung diseases
Current Opinion in Pulmonary Medicine, 2014An overview over the role of lung transplantation in interstitial lung diseases will be given.Lung transplantation is an established therapy option for patients with various end-stage lung diseases. Currently, the worldwide procedural frequency is about 3600 per year.
openaire +2 more sources
Lung Transplantation for Interstitial Lung Disease
Clinics in Chest Medicine, 2012For selected parenchymal lung disease patients who fail to respond to medical therapy and demonstrate declines in function that place them at increased risk for mortality, lung transplantation should be considered. Lung transplantation remains a complex medical intervention that requires a dedicated recipient and medical team.
openaire +2 more sources
Disease-a-month : DM, 1991
The interstitial lung diseases are comprised of a group of pulmonary disorders characterized clinically by diffuse infiltrates on the chest radiograph and histologically by distortion of the gas exchanging portion of the lung. The physiologic correlates are restriction of lung volumes and impaired oxygenation.
W J, DePaso, R H, Winterbauer
openaire +1 more source
The interstitial lung diseases are comprised of a group of pulmonary disorders characterized clinically by diffuse infiltrates on the chest radiograph and histologically by distortion of the gas exchanging portion of the lung. The physiologic correlates are restriction of lung volumes and impaired oxygenation.
W J, DePaso, R H, Winterbauer
openaire +1 more source